OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for head and neck cancer patients unable to take standard chemo
Disease control CompletedThis study tested two different drugs—durvalumab or cetuximab—given together with radiation therapy for people with advanced head and neck cancer who cannot take the standard chemotherapy drug cisplatin. The goal was to see which combination works better and is safer. A total of …
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:54 UTC
-
Real-world data on throat cancer treatments could shape future studies
Knowledge-focused CompletedThis study looked at 662 people with HPV-positive throat cancer that had spread or come back. Researchers checked how patients were treated with pembrolizumab or nivolumab (with or without chemo) in real-world clinics. The goal was to gather information to help design better futu…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Hookipa Biotech GmbH • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC